Leukemia, Myelodysplasia, Transplantation
Conference Coverage
Most community-based oncologists skip biomarker testing
Survey shows that 48% of community clinicians use biomarker testing to guide treatment decisions, compared with 73% of academic clinicians.
News
Immunotherapy for cancer patients with poor PS needs a rethink
Patients should not receive immunotherapy just to reduce risk of side effects, doctor says.
News
Transfusions, readmissions higher for patients with CLL after cardiac surgery
Latest News
One in three cancer articles on social media has wrong info
Physician says misleading information online may be harmful to patients.
Conference Coverage
Ponatinib/blinatumomab start strong against Ph+ALL
Conference Coverage
Reduced-intensity transplant benefits older patients with AML
Article
The power and promise of social media in oncology
Dr. Alan Lyss describes a recent presentation on the role of social media in oncology.
Clinical Topics & News
Atrial Fibrillation and Bleeding in Patients With Chronic Lymphocytic Leukemia Treated with Ibrutinib in the Veterans Health Administration
Although ibrutinib is associated with increased bleeding-related adverse events, the risk for patients with chronic lymphocytic leukemia is...
News
Predicting outcomes in therapy-related AML
News
GENUINE improvements: Ublituximab plus ibrutinib for CLL
